Understand the source comparison
Research Peptides: Synthesis vs Off-Label Use Comparison
Research laboratory use Laboratory reagent. Not FDA-approved for human use ≥98% purity, HPLC + mass spec verified, CoA required Contamination, incorrect sequencing, improper storage Designed for controlled biological studies, not therapeutic administration. Re
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research laboratory use
- Laboratory reagent. Not FDA-approved for human use
- ≥98% purity, HPLC + mass spec verified, CoA required
- Contamination, incorrect sequencing, improper storage
- Designed for controlled biological studies, not therapeutic administration. Requires institution-level oversight and safety protocols
- Off-label clinical use
- Compounded medication (503B outsourcing facility) or prescription under physician supervision
- USP Chapter <797> sterile compounding standards, endotoxin testing <0.5 EU/mg
- Gastrointestinal adverse events, injection site reactions, contraindications (e.g., MEN2 syndrome for GLP-1 agonists)
- Therapeutic use requires prescribing authority, patient-specific risk assessment, and FDA-registered compounding pharmacy. Not interchangeable with research-grade material
- Consumer supplement market
- Dietary supplement (FDA DSHEA regulation) or unregulated product
- No purity or sequencing verification required, no third-party testing standard
- Unknown peptide content, contamination, mislabeling, no bioavailability data
- Oral peptide bioavailability is near-zero for most sequences due to gastric degradation. Marketing claims rarely align with pharmacokinetic reality